Raymond E Farah
Impact in
-
- Diet, Metabolism, and Disease
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
-
- Vasculitis and related conditions 2
-
- COVID-19 Clinical Research Studies 3
- Clostridium difficile and Clostridium perfringens research 3
- Co-authors
- Rola Khamisy‐Farah (24 shared papers)William Nseir (12 shared papers)Nimer Assy (4 shared papers)Maria Grosovski (2 shared papers)Revital Shurtz-Swirski (9 shared papers)Alon T Marmor (1 shared paper)Agness Djibre (1 shared paper)Julnar Mograbi (6 shared papers)
- Journals
- Journal of Clinical Laboratory Analysis (6 papers)European Journal of Internal Medicine (5 papers)Annals of Pharmacotherapy (4 papers)Experimental and Clinical Endocrinology & Diabetes (3 papers)JMIR Medical Education (2 papers)
- Partner nations
- IsraelCanadaUnited States
In The Last Decade
Raymond E Farah
86 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 131
- Endocrinology, Diabetes and Metabolism 263
- Epidemiology 517
- Internal Medicine 40
- Hepatology 62
- Infectious Diseases 143
Countries citing papers authored by Raymond E Farah
This map shows the geographic impact of Raymond E Farah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond E Farah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond E Farah more than expected).
Fields of papers citing papers by Raymond E Farah
This network shows the impact of papers produced by Raymond E Farah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond E Farah. The network helps show where Raymond E Farah may publish in the future.
Co-authors
The 25 scholars most cited alongside Raymond E Farah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 225 | |
| 2 | 2010 | 166 | |
| 3 | 2013 | 90 | |
| 4 | 2017 | 86 | |
| 5 | 2007 | 85 | |
| 6 | 2014 | 50 | |
| 7 | 2019 | 45 | |
| 8 | 2017 | 41 | |
| 9 | 2017 | 40 | |
| 10 | 2008 | 36 | |
| 11 | Insulin therapy of hyperglycemia in intensive care. | 2007 | 29 |
| 12 | 2016 | 29 | |
| 13 | 2001 | 27 | |
| 14 | 2015 | 27 | |
| 15 | 2020 | 25 | |
| 16 | 2008 | 24 | |
| 17 | 2015 | 24 | |
| 18 | 2012 | 22 | |
| 19 | 2019 | 22 | |
| 20 | 2013 | 21 |
About Raymond E Farah
Raymond E Farah is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Epidemiology, Oncology and Rheumatology, having authored 90 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (4 papers), COVID-19 Clinical Research Studies (3 papers), Sex and Gender in Healthcare (3 papers), Urticaria and Related Conditions (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Vasculitis and related conditions (2 papers) and Sarcoidosis and Beryllium Toxicity Research (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (263 citations), Epidemiology (517 citations), Internal Medicine (40 citations), Hepatology (62 citations) and Infectious Diseases (143 citations). Raymond E Farah has collaborated with scholars based in Israel, Canada and United States. Frequent co-authors include Rola Khamisy‐Farah, William Nseir, Nimer Assy, Maria Grosovski, Revital Shurtz-Swirski, Alon T Marmor, Agness Djibre, Julnar Mograbi, Mahmud Mahamid and Jihad Bishara. Their work appears in journals such as Journal of Clinical Laboratory Analysis, European Journal of Internal Medicine, Annals of Pharmacotherapy, Experimental and Clinical Endocrinology & Diabetes and JMIR Medical Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.